Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01210209|
Recruitment Status : Unknown
Verified September 2010 by National Cancer Institute (NCI).
Recruitment status was: Recruiting
First Posted : September 28, 2010
Last Update Posted : August 26, 2013
RATIONALE: Studying samples of blood in the laboratory from patients with cancer and their relatives may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at blood samples collected from patients with Ewing sarcoma and their relatives.
|Condition or disease||Intervention/treatment|
|Sarcoma||Other: genome-wide association study|
- To identify and characterize a genetic susceptibility factor to Ewing's sarcoma by performing a Genome-Wide Association Study with as many as possible Ewing sarcoma patients.
OUTLINE: This is a multicenter study.
Blood samples are collected from patients and their relatives. Blood DNA samples are analyzed for susceptibility genes of Ewing Sarcoma.
|Study Type :||Observational|
|Estimated Enrollment :||600 participants|
|Official Title:||GENEWING - A Genome Wide Association Study in Ewing Sarcoma|
|Study Start Date :||September 2009|
|Estimated Primary Completion Date :||September 2011|
- Identification and characterization of susceptibility genes in patients with Ewing sarcoma
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01210209
|Institut Curie Hopital||Recruiting|
|Paris, France, 75005|
|Contact: Contact Person 33-1-5624-6679 firstname.lastname@example.org|
|Principal Investigator:||Olivier Delattre, MD||Institut Curie|